e-Therapeutics (ETX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

10.00p
   
  • Change Today:
      0.60p
  • 52 Week High: 23.10
  • 52 Week Low: 8.13
  • Currency: UK Pounds
  • Shares Issued: 584.34m
  • Volume: 721,694
  • Market Cap: £58.43m

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
17-Aug-15 N 1 Singer Corporate 39.00p - - Reiteration
16-Sep-14 Panmure Gordon Buy - - 70.00p Reiteration
08-May-14 Panmure Gordon Buy - 70.00p 70.00p Reiteration
26-Mar-14 Panmure Gordon Buy - 70.00p 70.00p Reiteration
07-Jan-14 Panmure Gordon Buy - 70.00p 70.00p Reiteration
21-Oct-13 Panmure Gordon Buy - 70.00p 70.00p Reiteration
11-Oct-13 Panmure Gordon Buy - 70.00p 70.00p Reiteration
10-May-13 Panmure Gordon Buy - 72.00p 67.00p Reiteration
18-Dec-12 Panmure Gordon Buy - 73.00p 73.00p Reiteration
22-Oct-12 Panmure Gordon Buy - 76.00p 73.00p Reiteration
19-Jun-12 Panmure Gordon Buy - 76.00p - Reiteration
21-May-12 Panmure Gordon Buy - 76.00p - Reiteration
18-Oct-11 Panmure Gordon Buy - 76.00p - Reiteration
22-Jul-11 Panmure Gordon Buy - 80.00p - Reiteration
15-Feb-11 Panmure Gordon Buy - 80.00p - Reiteration
30-Sep-10 Panmure Gordon Buy - - 80.00p New Coverage

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

e-Therapeutics Market Data

Currency UK Pounds
Share Price 10.00p
Change Today 0.60p
% Change 6.38 %
52 Week High 23.10
52 Week Low 8.13
Volume 721,694
Shares Issued 584.34m
Market Cap £58.43m

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
21.53% below the market average21.53% below the market average21.53% below the market average21.53% below the market average21.53% below the market average
60.78% above the sector average60.78% above the sector average60.78% above the sector average60.78% above the sector average60.78% above the sector average
Price Trend
60.02% below the market average60.02% below the market average60.02% below the market average60.02% below the market average60.02% below the market average
5.45% above the sector average5.45% above the sector average5.45% above the sector average5.45% above the sector average5.45% above the sector average
Income Not Available
Growth
15.57% below the market average15.57% below the market average15.57% below the market average15.57% below the market average15.57% below the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average

e-Therapeutics Dividends

No dividends found

Trades for 07-May-2024

Time Volume / Share Price
10:36 17 @ 9.65p
09:33 150,000 @ 10.11p
09:28 187,072 @ 11.22p
10:16 89 @ 9.60p
09:28 50,000 @ 10.05p

e-Therapeutics Key Personnel

Chair Trevor Mervyn Jones
CEO Ali Mortazavi

Top of Page